Explants of embryonic lung are often used to characterize lung growth, bronchial tree pattern, and cell diftetentiation. Most investigators culture lungs for 3-7 days in defined media lacking, e.g., added growth factors or hormones. Ifgrowth and differentiation are comparable to that in vivo, these cultures show considerable promise for identifying developmental regulatory molecules and target genes, and for elucidating molecular responses. We used in situ hybridization and RT-PCR to compare times and sites of expression of mRNAs of six epithelial genes in cultured and uncultured fetal rat lungs. These genes, expressed in distal lung of adult rats, are surfactant proteins (SP) A, B, and C; LAR, a receptortype tyrosine phosphatase; Clara ceJl secretory protein (CClO,
Introduction
The cultured embryonic lung (rat or mouse) is widely used to identify the regulators of lung development. Early studies by Slavkin and colleagues (Slavkin et al., 1989; Jaskoll et al., 1984) , using embryonic mouse lung, showed that the lung grows and develops a complex system of branching tubules when explanted and cultured in defined media. Since then, many studies have shown that lung development in vitro can be experimentally altered, such as by changes in EGF (Warburton et al.; 1332) , PDGF , TGFPl (Serra and Moses, 1995; Serra et al., 1994 ). or TNFa uaskoll et al., 1994 . or other growth factors, by extracellular matrix components, such as laminin (Matter and Laurie, 1994; Schuger et al., 1990) , tenascin (Young et al., 1994) , or RGD-containing peptides (Roman et al., 1991) , by glucocorticoids (Deterding et al., 1994) and other hormones (Floros et al., 1991) . and by morphogens such as retinoids (Cardoso et al., 1995) . Although the molecular mech-I Supported by PO1 47049 from the National Heart, Blood, and Lung Correspondence to: Mary C. Williams. Pulmonary Center, Boston U.
Institute.
School of Medicine, 80 E. Concord St., Boston, MA 02118. CCSP); and Tla. SPA, SPB, LAR, and CClO are expressed by both Clara and Type II cells in adult animals. SPC and T l a are unique markers for Type I1 and Type I cells, respectively. SPC, LAR, and T l a are expressed before the lung is explanted (Day US); SPA, -B, and CClO "As are first detected later. The onset of expression is similar in vivo and in vitro. Although the patterns of expression differ for each "A, their sites of expression in culture match those in vivo relative to the bronchial tree. The explanted embryonic lung appears to be an excellent experimental model. anisms by which these agents influence lung morphogenesis are not established, they would be expected to act through signaling pathways that alter gene expression in the target cells. Most commonly the cultured lung responds to these substances by decreasing or increasing the growth or complexity of branching of the bronchial tree (Jaskoll et al., 1994; Souza et al., 1994; Roman et al., 1991; Schuger et al., 1990) . In a few studies, alterations in bronchial tree pattern have been correlated with alterations in epithelial phenotype, i.e., gene expression, such as the proximaliting effects of retinoids and SP-A, -B, and -C expression (Cardoso et al., 1995) or the alteration of N-myc expression by E F P 1 (Serra and Moses, 1995; Serra et al., 1994) .
The usefulness of embryonic lung cultures for developmental studies depends largely on whether gene expression in the lung ex vivo is similar to that in vivo. In particular, it is important to know whether epithelial genes are expressed at times and locations (relative to the bronchial tree) that match those in vivo. Descriptive morphological studies indicate that this may be correct, given that ciliated cells, lamellar body-and glycogen-containing cells, and mesenchymal derivatives, such as smooth muscle, develop at appropriate sites in the proximal-distal axis of the explanted lung (Cardoso et al., 1995; Slavkin et al., 1989) .
MENEGHETI'I, CARDOSO, BRODY, WILLIAMS
We used in situ hybridization and RT-PCR amplification to map the sites of expression in vitro of epithelial marker genes and to determine when expression begins. We compared these findings with the patterns of gene expression in normal fetal lungs of matched gestational age. We selected genes for study that have wellcharacterized sites of expression in the distal adult lung. These include surfactant proteins (SP) SP-A, SP-B, CC10, a receptor-type tyrosine phosphatase LAR (Katsura et al., 1995) , all of which are expressed in rodents in both alveolar Type I1 and bronchiolar Clara cells, SP-C, a marker for Type I1 cells, and Tla, a marker for Type I cells (Williams et al., 1996; Rishi et al., 1995; Williams and Dobbs, 1990; Dobbs et al., 1988) . Using a monoclonal antibody, we also characterized Tla protein expression in vitro by immunohistochemistry to compare it with in vivo expression (Williams et al., 1996; Williams and Dobbs, 1990 ). Although each of these genes has a distinctive pattern and time of expression, the spatial and temporal patterns of gene expression in vitro reliably mimic those of the normal fetal lung.
Materials and Methods
Animals. Timed-pregnant Sprague-Dawley rats were purchased from Zivic-Miller (Allison Park, PA) and housed under standard conditions for 2-3 days before use. For analysis of in vivo development, dams were anesthetized with sodium methohexital. embryos were removed, and the lungs were dissected free of other organs for mRNA extraction and PCR analysis. In situ hybridization studies were carried out on both isolated lungs and whole embryos, the latter being used particularly for small embryos (Day 13.5). Lungs were similarly obtained daily thereafter to term (Day 22). Lungs of 13.5 gestational days were removed aseptically and cultured for 5 days in defined media according to methods described earlier (Cardoso et al., 1995) .
Preparation of Tissues. Dissected lungs or whole embryos were fixed in freshly prepared, sterile 4% paraformaldehyde and processed for paraffin embedding according to the method of Sassoon et al. (1988) as we have previously described (Rishi et al., 1995) .
Marker genes: The following genes were selected as markers for type I1 or type I alveolar epithelial cell phenotypes. Their cellular specificities in adult rat lung are noted in parentheses: SP-A and SP-B (Type I1 and Clara cells) Kalina et al., 1992; Auten et al., 1990) , SP-C (Type I1 cells) (Kalina et al., 1992; . CClO (CCSP) (Type I1 and Clara cells) (Hackett et al.. 1992; Katyal et al., 1990) . and T l a (Type I cells) (Rishi et al., 1995) . Localization of LAR mRNA (Type I1 and Clara cells) in normal fetal lung has been reported elsewhere (Katsura et al., 1995) ; we present here new observations on cultured lung. The following cDNA fragments for these genes were cloned into the pBluescript SK+ vector, and appropriate linearized templates were prepared for generating 3'S-labeled. singlestranded riboprobes using T7 and T3 polymerases: SP-A, 504 BP from + 160 to +664 (Sano et al., 1987) ; SP-B, 480 BP from +289 to +769 (Emrie et al., 1989) ; SP-C. 574 BP from + 2 2 to +596 (Fisher et al., 1989) ; CClO, 274 BP from +54 to +328 (Katyal et al.. 1960) ; Tla, 523 BP from +310 to +833 (Rishi et al., 1995) ; and LAR, 360 BP from amino acids 1045 to 1068 (Krueger et al., 1990) .
Preparation of 35S-labeled Riboprobes. High specific activity riboprobes were synthesized, purified by column chromatography, and hydrolyzed with Na2CO3-NaHCO3 to an average size of 150 nts as described previously (Krueger et al.. 1990) .
In Situ Hybridization. The protocol detailed previously was followed exactly and is summarized here. Paraffin sections were rehydrated, rinsed, treated with proteinase K, and hybridized overnight at 52'C with 30,000 cpmlpl probe. Rinses and treatment with RNAse A were as previously described. NTB2 emulsion-coated slides were developed after 1 or 3 weeks of exposure and photographed with phase-contrast or darkfield optics in a Leitz Orthoplan microscope.
Immunohistochemistry. Paraffin sections 6 mm thick were mounted on Vectabond coated slides (Vector; Burlingame, CA) and rehydrated through alcohols. Sections were blocked with 1% normal goat serum and treated overnight at 4°C with various dilutions (1:lO-1:lOOO) of hybridoma supernatant containing a monoclonal antibody against the T l a protein, produced by A. WetterwaJd (Williams et al., 1996) . On Western blots this antibody identifies a single 3 6 -~~ protein in homogenates of adult rat lung. As we have shown by transfection studies in COS cells (Williams et al., 1996) , this band is T l a protein. After incubation with the primary antibody slides were washed and treated with reagents in the Vectastain ABC kit (Vector) according to the manufacturer's directions.
mRNA Extraction and PCR Analysis. "As were prepared for RT-PCR analysis using the Micro-Fast Track extraction kit (Invitrogen; San Diego. CA) and stored at -70°C until use. All samples were treated with DNAse before RT. RT was carried out according to the method of Kawasaki and Wang (1989) as detailed earlier (Rishi et al., 1995) . Amplification was carried out according to our earlier description (Rishi et al., 1995) , using a DNA thermocycler from M. J. Research (Watertown, MA) and a 30-cycle amplification protocol. Amplified DNA was analyzed by agarose gel electrophoresis. Oligonucleotide primers for &actin, SP-A, Tla, are listed elsewhere (Rishi et al., 1995) ; for SP-B and SP-C (Cardoso et al., 1995), and for LAR (Katsura et al., 1995) . Primers for CClO amplification were (5') CACTGT-GCTCATGCTGTCC and (3') GCTCACACAGAGGACTTGTTAGG.
RT-PCR
The mRNAs for Tla, SP-C, and LAR are present in Day 13.5 lungs before explanting and they remain present throughout the culture period. We have routinely been unable to detect SP-A, -B, or CClO at 13.5 days of gestation. SP-A mRNA is first detectable on Day 15.5 SP-B and CClO are both detected one day earlier, on Day 14.5 (Table 1 ). In vivo and in vitro timing of mRNA expression for all three genes is similar. 
In Vivo Expression in Day 12-14 Embryos
Transcripts for Tla and SP-C were detected by in situ hybridization on Day 12 before the formation of an endodermal outgrowth that can be recognized visually and dissected from the embryo. Tla is expressed on Days 10-12 in neural and gut-derived epithelia (primitive esophagus and trachea) as described previously (Rishi et al., 1995) . In Day 12 embryos, SP-C mRNA is present only in the presumptive trachea and not in the esophagus (data not shown). Both genes appear to be expressed in all epithelial cells of the presumptive trachea.
Within the next 25-36 hr of development, the sites of expression of these genes diverge and the levels of expression of both appear to increase. Tla is expressed by epithelia of proximal portions of the bronchial tree (Rishi et al., 1995) whereas SP-C transcripts are restricted to the most distal tips of the branching tubules ( Figures  1A-ID) . LAR mRNA is detectable in the entire bronchial tree (Figures 1E and IF) . Several in situ hybridization experiments and the RT/PCR experiments noted above failed to demonstrate SP-A, SP-B, or CClO transcripts on Days 12-14. Both methods reproducibly showed expression of these genes at later times in gestation and in adult lungs.
Expression in Day S Cuhured Lungs
All six transcripts are expressed in epithelia of lungs explanted into defined media (Figure 2) by culture Day 5. In situ signals for SP-C, apparently of high abundance, are localized to terminal buds ( Figures 2C. 3A, and 3B ). These structures are morphologically distinct from larger airways (see Figure 1 ). Although some SP-C-positive tubules identified in Figure IC (arrows) are located in the center of the explant, their morphology indicates that they are peripheral tubules. By Day 5, SP-A (Figures 2A, 4A, and 4B ) and SP-B ( Figures  2B. 4C, and 4D ) mRNAs are present in SP-C-expressing cells, although transcripts are first seen in small numbers of cells in tubules immediately proximal to the SP-C-positive cells (Figure 2) .
The restricted pattern of expression of SP-A, -B, and -C contrasts with widespread expression patterns of LAR and CCIO. LAR transcripts ( Figure 2E ) are found throughout the entire bronchial tree with approximately the same intensity of signal. CClO is similarly expressed in the entire epithelium, but the signal is of highest intensity in proximal airways and decreases progressively along the proximal to distal axis ( Figure 2D ).
Of the six genes, Tla has the least definitive pattern of expres- sion in early lungs because transcripts appear to be of relatively low abundance throughout the 5 days ofculture. Tla mRNA and protein appear to be nonuniformly expressed in the bronchial tree, but this is less obvious in vitro than in vivo and is less obvious for mRNA than for protein (Williams et al., 1996) . On embryonic Days 13-13.5, expression is limited to proximal regions of the bronchial tree (Rishi et al., 1995) . By culture Day 5, both mRNA and protein are present at low levels in large airways, with higher signals in midsized tubules (Figures 2F and 5) . Many but not all of the SP-Cpositive terminal buds express Tla. This pattern reflects that seen in normal fetal lung by gestational Day 18 (see below).
In Vivo Gene Expression
By Day 18 the patterns of expression of SP-A ( Figures 6A and 6B ). -B ( Figures 6C and 6D) , and -C ( Figures 6E and 6F) are similar. and transcripts are localized to cells of the tubule buds. Some SP-C-positive cells appear to express SP-B but not SP-A, whose expression appears to lag behind SP-B slightly. At this time, neither SP-A nor SP-B mRNA is reproducibly found in small bronchioles or larger airways that express CClO (Figures 6A-6D ). CClO expression ( Figures  6G and 6H) is very low or not detectable in the SP-C-expressing tubules but is present, apparently in very high abundance, in the largest airways and trachea. Some CClo expression is detectable in the small bronchioles that can now be identified by their location and circumferential smooth muscle. LAR is uniformly distributed within the bronchial tree (Figures 61 and 6J) . Tla ( Figures  6K and 6L) . on the other hand, is expressed in middle-sized bronchioles and some but not all SP-C-positive tubules.
By Day 21 (not shown), low levels of expression of SP-A and -B transcripts are detectable in the small bronchioles, but the intensity of signal is much lower than in SP-C-positive cells. Therefore, there may be differences in the regulation of SP-A and -B between presumptive Type I1 and Clara cells, as suggested by earlier studies. LAR mRNA, although still expressed throughout the bronchial tree, appears to decrease in abundance by Day 21, in contrast to Tla, which does the opposite. Tla mRNA is present only in the peripheral lung and is not present in bronchioles of any size. CClO is highly expressed in bronchioles of all sizes and is not expressed (or at low levels) in peripheral lung. In adult rat, CClO transcripts are routinely detectable in alveolar Type I1 cells.
Discussion
The patterns of epithelial gene expression that are characteristic of normal lung development appear to be faithfully reproduced by the cultured lung for at least 5 days after explanting, making these culture preparations useful for many studies. That the explanted lung is capable of expressing epithelial genes with the correct spatial and temporal pattern suggests that the developmental program directing expression of many epithelial genes is inherent in the lung and is established very early in embryogenesis.
For short culture periods, analogous to fetal Days 13-18, epithelial development appears normal. Not all of the structural and biochemical features of the adult lung are acquired during this time, either in vitro or in vivo, however. The bronchial tree is foreshortened in culture, angiogenesis appears to cease, and the overall growth of the lung is less than that in vivo. Also notable are the incomplete restriction of certain genes, such as LAR, to a limited number of epithelial cell types and the lack of morphologically differentiated Type I cells. The failure to form attenuated Type I cells is not simply due to a delay in maturation in vitro, because lungs cultured for longer times also lack typical Type I cells (unpublished data). These differences lead us to believe that the cultured lung is a useful model for studies of early regulation of branching and of modulation of epithelial gene expression but may not be suitable in its present form for studies of late fetal events, such as expression of many antioxidant enzymes (Frank and Sosenko, 1987) , and early postnatal changes, such as alveolar septation (Massaro and Massaro, 1992) .
The six distal genes we studied have patterns of expression that are similar in vitro and in vivo, but they differ from each other in striking ways. The most interesting pattern is the restriction of SP-C transcripts (Day 13 and thereafter) to distal segments of the growing bronchial tree, as has been noted earlier (Wert et al.. 1993; . Restriction must occur within the 24 hr before explanting, because 1 day earlier (Day 12) SP-C transcripts are detectable in cells of the primitive lung that co-express Tla mRNA.
The restriction of SP-C expression to the termini of the epithelial tubules could suggest the commitment of the distal tip cells to an alveolar fate, but our previous study shows that expression of SP-C mRNA in this cell population (Day 13 lungs) can be influenced by exogenous substances such as retinoids. Treating the cultures with retinoids (Cardoso et al., 1995) suppresses SP-C expression in this cell population and simultaneously produces a proximal phenotype in the whole organ. A later in vitro exposure to retinoids has no effect on SP-C expression, suggesting that the cells may still have some plasticity at early times in development (Cardoso et al., 1995) . For much of early development, Tla and SP-C mRNAs are largely expressed in different populations of cells, although this is more evident for the protein (Williams et al., 1996) than for mRNA and is more obvious in vivo than in vitro. On Day 12, both Tla and SP-C mRNAs are present in the presumptive trachea, but the two mRNAs are quickly segregated into distinct cell populations and remain so until later in development. This pattern is maintained for Tla protein, which is most prominent in epithelial cells im- mediately proximal to SP-C-expressing cells (Williams et al., 1996) . As the lung grows and branches, T l a protein declines in the most proximal epithelial cells (i.e., tracheal end), whereas expression is maintained in the mid-sections of the tubules (Williams et al., 1996) . Very late in development, about Days 18-20, T!a protein abundance increases dramatically and is present in presumptive alveoli.
This pattem is sustained during the development of new generations of tubules and is reminiscent of the behavior of cultured adult rat Type I1 cells, which reversibly express Type I1 or Type I cell genes but apparently not both (Shannon et al., 1990 (Shannon et al., , 1992 Danto et al., 1995) . We are not aware of any studies that describe in detail the developmental expression pattern of other Type I cell mRNAs, so it is unclear whether the patterns of T l a expression we observe are representative of other markers for this cell type.
The time of onset of SP-A and SP-B expression is similar for the two genes, but the location at which these mRNAs are first observed differs somewhat. This has been previously observed in fetal rabbit , in which SP-A and SP-B are expressed at "alveolar" and "prealveolar" cells, the former being the SP-C-positive cells and the latter being cells immediately proximal or upstream to SP-C. We have not been able to detect SP-A or SP-B transcripts in vivo or in vitro by either RT-PCR or in situ hybridization before gestational Day 14.5, although other investigators using PCR report the presence of both transcripts in Day 13 fetal rat lungs . Although we are not certain why there is this difference in findings, RT-PCR protocols may vary somewhat or there may be small but variable numbers of these transcripts in early lungs that are not detectable by in situ hybridization.
In adult lung, CC10 and LAR are expressed in high abundance in Clara cells, although both transcripts can be detected both by in situ hybridization (this study) and biochemically in Type I1 cells (Katsura et al., 1995; Guy et al., 1992) . Developmental expression of these genes in vitro and in vivo, particularly CC10, mirrors this distribution, with intense in situ hybridization signals in larger tubules and much lower signals in the distal tubules. By RT-PCR, CClO can first be detected on Day 14.5.
The developmental pattern of expression of LAR differs from the other genes studied in that is is expressed by all epithelial cells in the embryonic lung but is restricted to Type I1 and Clara cells in the adult (Katsura et al., 1995) . The restriction of LAR must occur postnatally because the adult pattern is not achieved in culture or in late fetal lung in vivo. LAR, and perhaps other receptortype tyrosine phosphatases, are believed to act as suppressors of cell proliferation (unpublished observations) and, in adult rat, LAR appears to be absent from epithelial cells other than those that act as stem cells (e.g., Type I1 and Clara cells, basal cells of the epidermis). Therefore, LAR transcription may be inhibited only when epithelial cells lose their proliferative potential and withdraw from the cell cycle postnatally, a possibility we have not yet studied experimentally.
In rat lung, none of the epithelial genes studied had identical expression patterns during development, although those in rat lung differ somewhat from other species (Khoor et al., 1994) . This suggests that, within the context of a developmental program, each gene is separately regulated. Although there is little specific data about transcriptional regulation of genes in developing lung Clevi-dence et al. (1994) have recently demonstrated that SP-B is dfierentially regulated by transcription factors of the hepatic nuclear factor/forkhead family, and SP-B has also been shown to be regulated by other transcription factors such as thyroid transcription factor (TTF-1) (Yan et al., 1995; Bohinski et al., 1994) . The study of Clevidence et al. (1994) shows that both HNF3a and HFH-8 can transactivate the SP-B promoter and that the former is expressed by Clara cells and the latter by Type I1 cells. Therefore, there can be differential expression of SP-B by different cell types utilizing different regulatory mechanisms. This observation is likely to serve as the prototype for the regulation of other epithelial genes. I t is reasonable to expect, therefore, that regulation of different transcription factors and their interactions with cir-acting elements in epithelial genes account for the varied phenotypes of the pulmonary epithelium and the specific characteristics of their developmental expression.
